The study found 4% of users reported "menstrual irregularities," according to Neil Sehgal, the study's first author.
Rezdiffra (resmetirom) is a brand-name drug prescribed for a type of liver disease called metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results